A detailed history of Graney & King, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Graney & King, LLC holds 182 shares of LLY stock, worth $185,949. This represents 0.1% of its overall portfolio holdings.

Number of Shares
182
Previous 181 0.55%
Holding current value
$185,949
Previous $141 Million 2.06%
% of portfolio
0.1%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$625.65 - $812.69 $625 - $812
1 Added 0.55%
182 $138 Million
Q2 2025

Aug 14, 2025

BUY
$713.71 - $898.95 $16,415 - $20,675
23 Added 14.56%
181 $141 Million
Q1 2025

May 14, 2025

BUY
$725.72 - $929.72 $9,434 - $12,086
13 Added 8.97%
158 $131 Million
Q4 2024

Feb 11, 2025

BUY
$727.2 - $932.06 $105,444 - $135,148
145 New
145 $112 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Graney & King, LLC Portfolio

Follow Graney & King, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graney & King, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graney & King, LLC with notifications on news.